InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Discover the full record of transactions filed by Sarna Surbhi, Director. Director active across 3 companies, notably PROGENITY, INC.. Aggregated, 9 disclosures have been published. Total volume traded: €489k. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
096,154 shares0
Common Stock
SEC:0000899243-22-023089:0·
€5,60728 shares@ €200.23740.0000% mcap1.1% of flow
Common Stock
SEC:0001321732-22-000035:0·
0710 shares0
Common Stock
SEC:0001321732-22-000027:0·
€23,58394 shares@ €250.88230.0002% mcap9.8% of flow
Common Stock
SEC:0001321732-22-000008·
€23,58394 shares@ €250.88230.0002% mcap4.8% of flow
Common Stock
SEC:0001321732-22-000008:0·
€218,229907 shares@ €240.60530.0017% mcap90.2% of flow
Common Stock
SEC:0001321732-21-000104·
€218,229907 shares@ €240.60530.0017% mcap44.6% of flow
Common Stock
SEC:0001321732-21-000104:0·
060,137 shares0
Common Stock
SEC:0000899243-21-027614·
060,137 shares0
Common Stock
SEC:0000899243-21-027614:0·
9 of 9 declarations
About Sarna Surbhi
Sarna Surbhi serves as a Board Member at Progenity, Inc., Penumbra Inc, and Biora Therapeutics, Inc. She brings significant expertise in corporate governance and strategy. Her role involves overseeing operations and ensuring that decisions made by the board align with the interests of shareholders and stakeholders. Sarna is involved in developing policies and practices that promote transparency and accountability within these companies.
